Antibiotics in the management of pediatric skin disease.
An increasingly large number of antibiotics are available for the treatment of uncomplicated skin and skin structure infections in children. Primary factors in the choice among these agents are the antibiotic resistance profile of the target pathogen(s), and the antibiotic's spectrum of activity, pharmacologic properties, potential adverse reactions and interactions and propensity to select for the emergence of resistant organisms. Based on a consideration of these principles, this article provides a practical guide to the use of antibiotics in the management of common cutaneous infections in the pediatric population.
Darmstadt
G L
GL
Department of Pediatrics, Children's Hospital & Medical Center, Seattle, Washington, USA.
D042462:4-Quinolones; D000284:Administration, Oral; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D000890:Anti-Infective Agents / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D004352:Drug Resistance, Microbial; D006801:Humans; D007223:Infant; D018942:Macrolides; D010406:Penicillins / Q000627:therapeutic use; D017192:Skin Diseases, Bacterial / Q000188:drug therapy*; D013211:Staphylococcus aureus / Q000187:drug effects; D013754:Tetracyclines
D042462:4-Quinolones; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D002511:Cephalosporins; D018942:Macrolides; D010406:Penicillins; D013754:Tetracyclines